ReviewJournal of fungi (Basel, Switzerland)2026
Dematiaceous Fungal Infections in Hematopoietic Stem Cell Transplantation and Predisposing Hematological Conditions: A Systematic Review.
Review in Journal of fungi (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDematiaceous fungi can cause invasive disease in patients with hematological malignancies and hematopoietic stem cell transplant (HSCT) recipients.
methodsTo characterize the spectrum of disease in these populations, we performed a systematic review of PubMed and Scopus databases (searched 16 August 2026) and included reports with individualized data on dematiaceous fungal infections in adult HSCT recipients and patients with predisposing hematological conditions. A four-domain bias assessment was applied to reports, and data were summarized with descriptive statistics.
resultsWe identified 74 reports on 88 patients. The median age was 58 years, 61% were male, and 35% (31/88) were HSCT recipients. The most common genus was
conclusionsAlthough limited by biases inherent to case reports, this review identified high all-cause mortality and frequent breakthrough infections. No funding sources were used, and this protocol was not registered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.